1. Copper homeostasis and Cuprotosis: Exploring novel therapeutic strategies for connective tissue diseases.
- Author
-
Zhang W, Song Z, Tian Y, Zhang R, Guo Z, Yang Y, Jiang X, and Zhang R
- Subjects
- Animals, Humans, Chelating Agents pharmacology, Chelating Agents therapeutic use, Regulated Cell Death drug effects, Connective Tissue Diseases drug therapy, Connective Tissue Diseases pathology, Copper metabolism, Homeostasis drug effects
- Abstract
Copper is an indispensable element for human health, with its balance being critical to prevent the onset of diseases, particularly those affecting connective tissues. Imbalances in copper levels can lead to pathological alterations. Research indicates that copper supplements and chelators hold promise for the treatment of certain conditions, yet the precise mechanisms by which copper imbalances and the cell death mechanism known as cuprotosis contribute to connective tissue diseases remain elusive. This paper delves into the potential role of copper imbalance and cuprotosis in connective tissue diseases and evaluates the underlying cellular mechanisms. The goal is to offer practical insights into targeted therapies for dysregulated copper metabolism, with the aim of devising novel strategies for the treatment of connective tissue diseases., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF